Sec. 3. As used in this chapter, “interchangeable” means:

(1) a determination by the federal Food and Drug Administration that a biosimilar product may be substituted for a reference biological product without the intervention of the health care provider that prescribed the biological product; or

Terms Used In Indiana Code 16-42-25-3

  • biological product: means :

    Indiana Code 16-42-25-1

  • biosimilar: refers to a biological product that:

    Indiana Code 16-42-25-2

(2) concerning a biological product filed under 21 U.S.C. § 355(b)(2), a product that is designated as therapeutically equivalent by the federal Food and Drug Administration in the Approved Drug Products with Therapeutic Equivalence Evaluations.

As added by P.L.96-2014, SEC.6.